Search
Pine needle oil (pinus mugo)
go.drugbank.com/drugs/DB11276ApprovedIt is present in aromatherapeutic agents as a massage oil or fragrance and may also be used as a disinfectant, lubricant, sanitizer, antimicrobial, insecticide and organic herbicide. … Major components of pine needle oil (pinus mugo) include α-Pinene, β-pinene, δ-3-carene, limonene, β-phellandrene, (E)-caryophyllene, and germacrene D.
Mixtures: Co CoolCategories: Herbs and Natural ProductsNalmefene
go.drugbank.com/drugs/DB06230ApprovedInvestigationalWithdrawn[L40684] It acts as an antagonist at the mu (μ)-opioid and delta (δ)-opioid receptors and a partial agonist at the kappa (κ)-opioid receptor. … [L40684] The nasal spray formulation of nalmefene was approved by the FDA in May 2023.[L46511]
Products: SELINCRO 18MG FILM KAPLI TABLET ,42 TABLET, SELINCRO 18MG FILM KAPLI TABLET ,7 TABLETFish oil
go.drugbank.com/drugs/DB13961ApprovedInvestigationalNutraceuticalSuch fish oils are available in both non-prescription and prescription-only varieties at different concentrations. … More commonly, fish oil refers to the omega-3-fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) [FDA Label].
Mixtures: Cleanse Gut And Colon, Eurobio® Omega-3 500mg Plus CoQ10 50mgProducts: CHAMPS DHA 100MG SOFTGEL CAPSULE, NN SUPA EPADual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide
go.drugbank.com/bio_entities/BE0001300TargetHumansMay act as a B-cell-associated adapter that regulates B-cell antigen receptor (BCR)-signaling downstream of PI3K
Polypeptides: Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositideArtemisia vulgaris pollen
go.drugbank.com/drugs/DB10372ApprovedArtemisia vulgaris pollen is the pollen of the Artemisia vulgaris plant. Artemisia vulgaris pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractProducts: Pollens - Weeds and Garden Plants, Sagebrush, Mugwort Artemisia vulgarisCapmatinib
go.drugbank.com/drugs/DB11791ApprovedInvestigational[L13347] The presence of the mutation must be confirmed by an FDA-approved test, such as the FoundationOne CDx assay (manufactured by Foundation Medicine, Inc.), which was approved by the FDA on the same … Manufactured by Novartis and marketed under the brand name Tabrecta, capmatinib was granted accelerated approval by the FDA on May 6, 2020,[L13380] for the treatment of NSCLC in patients whose tumors have
Categories: Antineoplastic and Immunomodulating AgentsProducts: TABRECTA FILM-COATED TABLET 150mg, Rahika 150mg Film-coated TabletBaloxavir marboxil
go.drugbank.com/drugs/DB13997ApprovedInvestigational[L4779] It was also approved by the European Commission on January 7, 2021.[L45241] … Baloxavir marboxil is an antiviral drug used to treat influenza. More specifically, it is a first-in-class cap-dependent endonuclease inhibitor that works to block influenza virus proliferation.
Categories: Baloxavir and prodrugsProducts: XOFLUZA FILM COATED TABLETS 20MG, XOFLUZA FILM-COATED TABLET 20MGFlunarizine
go.drugbank.com/drugs/DB04841ApprovedInvestigationalIt is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. … Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity.
Categories: Calcium-Regulating Hormones and AgentsProducts: NATIL N 10MG, NATIL N 5MGLactulose
go.drugbank.com/drugs/DB00581ApprovedInvestigationaland its first clinical use for treating PSE was not until 1966. … [L6202] Nevertheless, although lactulose received formal FDA approval in 1977 and has since become a readily available generic and brand-name non-prescription medication listed on the World Health
Categories: Alimentary Tract and MetabolismSynonyms: 4-O-beta-D-Galactopyranosyl-D-fructose, 4-O-beta-D-Galactopyranosyl-D-fructofuranoseTepotinib
go.drugbank.com/drugs/DB15133ApprovedInvestigationalTepotinib was first approved in Japan in March 2020 for the treatment of non-small cell lung cancers (NSCLC) with _MET_ alterations, and was subsequently granted accelerated approval by the US FDA in February … Anderson Cancer Center in 2009 and has since been investigated in the treatment of neuroblastoma,[A228053] gastric cancers,[A228033] non-small cell lung cancer, and hepatocellular carcinoma.
Categories: Antineoplastic and Immunomodulating AgentsProducts: TEPMETKO FILM-COATED TABLET 225MG